Roncoroni, L.P.; Weiss, D.; Hieber, L.; Sturm, J.; Börtlein, A.; Mayr, I.; Appy, M.; Kühnler, B.; Buchthal, J.; Dippon, C.;
et al. Health-Related Quality of Life Outcomes from Botulinum Toxin Treatment in Spasticity. Toxins 2020, 12, 292.
https://doi.org/10.3390/toxins12050292
AMA Style
Roncoroni LP, Weiss D, Hieber L, Sturm J, Börtlein A, Mayr I, Appy M, Kühnler B, Buchthal J, Dippon C,
et al. Health-Related Quality of Life Outcomes from Botulinum Toxin Treatment in Spasticity. Toxins. 2020; 12(5):292.
https://doi.org/10.3390/toxins12050292
Chicago/Turabian Style
Roncoroni, Lorenzo Pietro, Daniel Weiss, Leonhard Hieber, Justine Sturm, Axel Börtlein, Ingo Mayr, Matthias Appy, Benedicta Kühnler, Joachim Buchthal, Christian Dippon,
and et al. 2020. "Health-Related Quality of Life Outcomes from Botulinum Toxin Treatment in Spasticity" Toxins 12, no. 5: 292.
https://doi.org/10.3390/toxins12050292
APA Style
Roncoroni, L. P., Weiss, D., Hieber, L., Sturm, J., Börtlein, A., Mayr, I., Appy, M., Kühnler, B., Buchthal, J., Dippon, C., Arnold, G., & Wächter, T.
(2020). Health-Related Quality of Life Outcomes from Botulinum Toxin Treatment in Spasticity. Toxins, 12(5), 292.
https://doi.org/10.3390/toxins12050292